Narrow search
Showing 1 - 5 of 5
Cover Image
How can health technology assessment be improved to optimise access to medicines? : results from a Delphi study in Europe
Fontrier, Anna-Maria; Kamphuis, Bregtje; Kanavos, Panos - In: The European journal of health economics 25 (2024) 6, pp. 935-950
Persistent link: https://www.econbiz.de/10014633345
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors
Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8
This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...
Persistent link: https://www.econbiz.de/10009503923
Cover Image
Macroeconomic constraints and health challenges facing European health systems
Kanavos, Panos; McKee, Martin - In: Critical challenges for health care reform in Europe, (pp. 23-52). 1998
Persistent link: https://www.econbiz.de/10001304568
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe: Overview and evidence from the market of ACE inhibitors
von der Schulenburg, Fritz; Vandoros, Sotiris; Kanavos, … - In: Health Economics Review 1 (2011) 18, pp. 1-8
This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...
Persistent link: https://www.econbiz.de/10010317156
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors
Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health Economics Review 1 (2011) 1, pp. 1-8
This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...
Persistent link: https://www.econbiz.de/10010593421